ELCC 2019: Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

Two studies to be reported at¬†ELCC 2019¬†provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC), where information has previously been lacking despite being the age group most commonly affected. Immunotherapy with drugs that target immune pathways to enhance the body’s ability to recognise and destroy … Continue reading ELCC 2019: Studies give new insights on immunotherapy in elderly patients with advanced NSCLC